To further validate whether PI3K/Akt signaling was involved in the pro-leukemia effects of miR-335 overexpression on K562 and HL60 cell-lines, MK-2206 2HCL which is an inhibitor of Akt was further used to block PI3K/Akt signaling pathway. The gene discussed is AKT1; the disease is leukemia.